Carlos Paz, MD
Procedural Dermatology · Fresno, CANPI 1275885709
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $193 and has fallen 72.3% since, to $54 in 2025. That places this record below the midpoint for procedural dermatology clinicians in CA, where the typical reported total is $2,566.
Across 31 payments — averaging $22.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Revance Therapeutics, Inc.$119
- AbbVie$117
- Sanofi$106
- Novartis$98
- Biofrontera Inc.$38
- Johnson & Johnson$36
- plus $179 from 8 others
What the payments were for
- Food & beverage$692100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Revance Therapeutics, Inc. | 2 | $119 |
| AbbVie(2 entities) | 6 | $117 |
| Sanofi | 4 | $106 |
| Novartis | 5 | $98 |
| Biofrontera Inc. | 2 | $38 |
| Johnson & Johnson | 2 | $36 |
| Pfizer | 2 | $36 |
| Lilly USA, LLC | 2 | $33 |
| Galderma Laboratories, L.p. | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| UCB, Inc. | 1 | $19 |
| Amgen | 1 | $18 |
| Incyte Corporation | 1 | $17 |
| LEO Pharma Inc. | 1 | $11 |
How this compares
$692 in reported general payments places this provider in the 30th percentile of 108 procedural dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minocycline Hcl | 288 | $2,084 |
| Cephalexin | 106 | $368 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 67 | $255 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 43 | $121 |
| Ciprofloxacin Hcl | 23 | $77 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Fresno
- Chia Yeh-ToFresno$7K
- Sam Khalifianla Mesa$3.5M
- Sabrina FabiSan Diego$3.1M
- Natasha MesinkovskaMission Viejo$499K
- Jeanette BlackLos Angeles$492K
- Mitchel GoldmanSan Diego$425K
- Rebecca FitzgeraldLos Angeles$230K
- Suzanne KilmerSacramento$220K
- Zakia RahmanStanford$181K
- Hrak JalianSanta Monica$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.